Notice of Half-Yearly Results

RNS Number : 4993W

PureTech Health PLC

19 August 2015

 



19 August 2015

PureTech Health plc

Notice of Half-Yearly Results

PureTech Health plc ("PureTech" or the "Company", LSE: PRTC), a science-driven healthcare company seeking to solve some of the toughest health challenges in disruptive ways, expects to announce its half-yearly results for the six months ended 30 June 2015 at at 7.00am BST on Tuesday 25 August 2015.

Enquiries:

PureTech Daphne Zohar, Chief Executive Officer Stephen Muniz, Executive Vice President, Legal, Finance and Operations Julie DiCarlo, Senior Vice President, Communications and Investor Relations	[phone]
FTI Consulting (Communications adviser to PureTech) Ben Atwell Matthew Cole Rob Winder Natalie Garland-Collins	[phone]

About PureTech

PureTech (PureTech Health plc, PRTC.L) is a science-driven healthcare company, seeking to solve some of today's toughest health challenges through disruptive approaches. Based in Boston, Massachusetts, PureTech has a pipeline of 12 operating companies, seven of which are "growth stage" with external validation including strategic partnerships, outside funding, proof-of-concept or peer review in prestigious scientific journals. PureTech is problem-focused and solution-agnostic, looking beyond traditional disciplines and approaching healthcare problems from different perspectives. Focusing on areas of significant unmet medical need, PureTech evaluates more than 650 ideas per year, prioritizing, selecting and testing what it believes to be the most scientifically and commercially promising concepts to advance. PureTech's leading team and board, along with an advisory network of more than 50 experts across multiple disciplines, gives PureTech access to potentially groundbreaking science and technological innovations. For more information, visit www.puretechhealth.com and connect with us on Twitter.

 

END

 

 

NORGGUGWRUPAGUB